Purdue Took Prompt Action When Problem Became Understood Adverse event reports involving MS Contin were always minimal. Adverse event reports involving OxyContin began sharply increasing in 2000. Purdue became aware of widespread abuse and diversion of OxyContin in different parts of the country in 2000, first from the U.S. Attorney in Maine. Purdue promptly supported … Continue reading Purdue Pharma Initiatives